Wed, Oct 22, 2014, 6:41 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • xwavve xwavve Jan 27, 2013 2:03 PM Flag

    4th Qtr Rev Blowout

    From the last earnings call, revenue from milestones alone will be $45 million, plus approximately$35 million in Adectris sales for the quarter, plus collaboration $. Revenue should be in the $100+ million range, almost double analysts unadjusted expectations, despite the CFO hinting the following in the previous earnings call. Look for a blowout, as the number to beat is approximately $57 million:

    "The fourth quarter of this will be particularly strong from a cash generation perspective. We expect to receive more than $100 million during the quarter which includes the $25 million Abbott collaboration payment, $25 million in approval milestone payments from Millennium, anticipated collections from ADCETRIS sales and other collaboration payments.

    Fourth quarter collaboration revenues will reflect approximately $7.7 million related to the European approval milestones from Millennium and we will begin to amortize the $25 million Abbott payment over the two-year development term of the expanded collaboration...."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SGEN
34.83-0.48(-1.36%)Oct 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.